2005
DOI: 10.1186/cc3890
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Direct haemoperfusion with polymyxin B-immobilized fibre (PMX-F) is a promising treatment for Gram-negative sepsis in critically ill patients. Indeed, it has been used routinely in Japan for a decade. Recent evidence presented in this journal suggests that PMX-F can have a positive impact on outcome in patients with sepsis, although other reports in the literature have presented confusing or even conflicting results. This commentary considers whether the available evidence allows us to establish an appropriate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 11 publications
0
9
0
Order By: Relevance
“…World over, the reported incidence of exit site infections vary from 6 to 15%, catheter tip infections from 4 to 15% and of CRBSIs from 1 to 13%. [ 16 17 ] While the IJV route is implicated to be more commonly associated with greater infectious complications,[ 1 18 ] in our patients, both routes of CVC insertion showed similar incidences of all three infectious complications.…”
Section: Discussionmentioning
confidence: 60%
“…World over, the reported incidence of exit site infections vary from 6 to 15%, catheter tip infections from 4 to 15% and of CRBSIs from 1 to 13%. [ 16 17 ] While the IJV route is implicated to be more commonly associated with greater infectious complications,[ 1 18 ] in our patients, both routes of CVC insertion showed similar incidences of all three infectious complications.…”
Section: Discussionmentioning
confidence: 60%
“…In addition, we believe the decision on immediate CVC removal or watchful waiting in patients with suspected CRI should take into account the following aspects for each patient: first, vascular accessibility, as new vascular catheterization may be very difficult in some cases due to poor vascular access; second, the risk of mechanical complications during new canalization that may even be life-threatening (for example, patients with coagulopathy or severe respiratory disease); third, the possibility that the CVC may not be the origin of the suspected CRI. In this regard, CVCs placed in the jugular vein of tracheostomized patients [ 16 ] or those placed in the femoral vein present a higher risk of CRBSI [ 17 ]; however, the risk of CRBSI decreases with the use of antimicrobial-impregnated catheters [ 18 ] and dressings [ 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…The risk of infection is affected by the catheter placement site, being more common after femoral (and, to a lesser extent, internal jugular vein) catheterization than after subclavian vein catheterization. 7 Thus, only patients with jugular vein catheters were included in the present study. The duration of catheterization is also a significant risk factor; CRBSI rates increase after six days of catheterization.…”
Section: Discussionmentioning
confidence: 99%